Maternal progesterone: impacts on conceptus development and conceptus-maternal interactions

Lillian X Ehresmann1, Rafael R Domingues1

  • 1Department of Animal Sciences, The Ohio State University, Columbus, OH, United States.

Reproduction (Cambridge, England)
|August 14, 2026
PubMed

In brief: Maternal progesterone modulates the uterine environment that governs conceptus elongation, signaling, and implantation in cattle, yet supplementation strategies inconsistently improve pregnancy success. This review synthesizes current understanding of progesterone-regulated conceptus-maternal interactions and highlights the use of longitudinal biomarkers (IFNT, ISG, and PAG) to better resolve how progesterone influences early pregnancy establishment. Abstract: Progesterone is the key maternal hormone regulating uterine function during early pregnancy to support the developing conceptus and promote uterine receptivity. In turn, the conceptus acquires the capacity to signal its presence and further modulates a maternal response to allow for attachment and initiation of placentation. Supplementation of progesterone is proposed to optimize conceptus-maternal interactions and favor pregnancy establishment due to advanced temporal changes in the uterine milieu allowing for hastened conceptus elongation. Nevertheless, supplemental progesterone has not consistently increased pregnancy per service when applied in beef or dairy cattle, indicating that further research is required. Beyond increasing conceptus elongation, the extent to which supplemental progesterone impacts conceptus development and signaling to favor pregnancy establishment remains poorly understood. Evaluation of interferon tau, interferon-stimulated genes, and pregnancy-associated glycoproteins can be used to infer about the progression of the conceptus through key developmental milestones but has not been widely applied in the context of progesterone supplementation. Importantly, assessment of these conceptus- and pregnancy-specific biomarkers may be performed in vivo and can provide more adequate insight into the timing of conceptus-maternal interactions in response to supplementation of progesterone, especially when examined temporally.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Ovarian Cycle01:27

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...